Home/Filings/3/0001104659-18-062797
3//SEC Filing

Avista Capital Partners III GP, L.P. 3

Accession 0001104659-18-062797

CIK 0001739426other

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 4:57 PM ET

Size

15.8 KB

Accession

0001104659-18-062797

Insider Transaction Report

Form 3
Period: 2018-10-18
Holdings
  • Ordinary Shares

    (indirect: By investment fund)
    4,936,926
  • Ordinary Shares

    (indirect: By investment fund)
    1,032,995
  • Ordinary Shares

    (indirect: By investment fund)
    4,825,916
  • Ordinary Shares

    (indirect: By investment fund)
    8,654,948
Footnotes (4)
  • [F1]Represents shares of the Issuer held by ACP III AIV, L.P. Avista Capital Partners III GP, L.P. ("ACP GP") is the general partner of ACP III AIV, L.P. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by ACP III AIV, L.P. Each of ACP III AIV, L.P. and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
  • [F2]Represents shares of the Issuer held by ACP Holdco (Offshore), L.P. ACP GP is the general partner of ACP Holdco (Offshore), L.P. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by ACP Holdco (Offshore), L.P. Each of ACP Holdco (Offshore), L.P. and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
  • [F3]Represents shares of the Issuer held by Orbit Co-Invest I LLC. ACP GP is the manager of Orbit Co-Invest I LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest I LLC. Each of Orbit Co-Invest I LLC. and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
  • [F4]Represents shares of the Issuer held by Orbit Co-Invest III LLC. ACP GP is the manager of Orbit Co-Invest III LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC.. Each of Orbit Co-Invest III LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.

Documents

1 file

Issuer

Osmotica Pharmaceuticals plc

CIK 0001739426

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001705722

Filing Metadata

Form type
3
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:57 PM ET
Size
15.8 KB